Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-12

Clinical Trial Update: Efficacy and Safety of Picroliv in Patients With Non-Alcoholic Fatty Liver Disease [NA]

View source ↗

Summary

Clinical trial update evaluating the efficacy and safety of Picroliv in adults with non-alcoholic fatty liver disease, currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Picroliv (Picroliv)

Snippet

Sponsor: Bioagile Therapeutics Pvt. Ltd. | Conditions: Non Alcholic Fatty Liver Disease | NA | Status: ENROLLING_BY_INVITATION